Haddadin Yezan Munther

EDGAR CIK 0001718004

Outlook Therapeutics, Inc. - OTLK

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
2
$39,105
63,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/02/2026
06/03/2026
Buy
29,000 @ $0.83
 $24,145 66,167 (78.03%) Direct
05/26/2026
05/27/2026
Buy
34,000 @ $0.44
 $14,960 37,167 (1,073.57%) Direct